Publications from Molecular and circuit neuropharmacology – Gilberto Fisone group

Selected publications

A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson's Disease for the Study of Non-Motor Symptoms.
Masini D, Plewnia C, Bertho M, Scalbert N, Caggiano V, Fisone G
Biomedicines 2021 May;9(6):

Involvement of Autophagy in Levodopa-Induced Dyskinesia.
Feyder M, Plewnia C, Lieberman OJ, Spigolon G, Piccin A, Urbina L, Dehay B, Li Q, Nilsson P, Altun M, Santini E, Sulzer D, Bezard E, Borgkvist A, Fisone G
Mov Disord 2021 05;36(5):1137-1146

Sleep Disorders in Rodent Models of Parkinson's Disease.
Medeiros DC, Lopes Aguiar C, Moraes MFD, Fisone G
Front Pharmacol 2019 ;10():1414

cJun N-terminal kinase (JNK) mediates cortico-striatal signaling in a model of Parkinson's disease.
Spigolon G, Cavaccini A, Trusel M, Tonini R, Fisone G
Neurobiol Dis 2018 02;110():37-46

Midbrain circuits that set locomotor speed and gait selection.
Caggiano V, Leiras R, Goñi-Erro H, Masini D, Bellardita C, Bouvier J, Caldeira V, Fisone G, Kiehn O
Nature 2018 01;553(7689):455-460

Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model.
Rivetti di Val Cervo P, Romanov RA, Spigolon G, Masini D, Martín-Montañez E, Toledo EM, La Manno G, Feyder M, Pifl C, Ng YH, Sánchez SP, Linnarsson S, Wernig M, Harkany T, Fisone G, Arenas E
Nat Biotechnol 2017 05;35(5):444-452

The histamine H3 receptor antagonist thioperamide rescues circadian rhythm and memory function in experimental parkinsonism.
Masini D, Lopes-Aguiar C, Bonito-Oliva A, Papadia D, Andersson R, Fisahn A, Fisone G
Transl Psychiatry 2017 04;7(4):e1088

A Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA-Induced Dyskinesia and ∆FosB Expression.
Feyder M, Södersten E, Santini E, Vialou V, LaPlant Q, Watts EL, Spigolon G, Hansen K, Caboche J, Nestler EJ, Fisone G
Biol Psychiatry 2016 Mar;79(5):362-371